Epson ink jet printers will be paired with Philips ultrasound medical imaging systems allover the world, wherever Epson printers are present. The incomparable Epson ESC/P-R Print Class Driver allows users to print to a full line of Epson ink jet printers from a wide range of digital equipment including Philips ultrasound medical imaging.
Wednesday 18 August 2010
Philips To Use Epson Ink Jet Printers
A new partnership between Epson America and Royal Philips Electronics has been announced, according to it, Epson ink jet printers will be paired with Philips ultrasound medical imaging systems allover the world, wherever Epson printers are present. The incomparable Epson ESC/P-R Print Class Driver allows users to print to a full line of Epson ink jet printers from a wide range of digital equipment including Philips ultrasound medical imaging.
Epson ink jet printers will be paired with Philips ultrasound medical imaging systems allover the world, wherever Epson printers are present. The incomparable Epson ESC/P-R Print Class Driver allows users to print to a full line of Epson ink jet printers from a wide range of digital equipment including Philips ultrasound medical imaging.
City Hospital In Birmingham Upgrades Its MRI Systems With Siemens's MAGNETOM Avanto
City Hospital in Birmingham has extended its range of imaging services and now offers faster and more streamlined MRI examinations following the installation of a MAGNETOM® Avanto 1.5 Tesla system from Siemens Healthcare. The hospital, part of Sandwell and West Birmingham Hospitals NHS Trust, upgraded its previous Siemens system to provide a refreshed, state-of-the-art service.
Philips Participates In The Venture Capital Fund For Innovative Healthcare
Royal Philips Electronics has announced its participation in the new venture capital fund, Gilde Healthcare III, for
innovative early and growth stage healthcare technology companies in Europe and the United States. Philips declared that its investment in Gilde Healthcare III is to ensure innovation and creativity in districts of special importance to its future healthcare business plans.
innovative early and growth stage healthcare technology companies in Europe and the United States. Philips declared that its investment in Gilde Healthcare III is to ensure innovation and creativity in districts of special importance to its future healthcare business plans.
BridgeHead Appoints A New EMEA Sales Operation Manager
Ashtead, UK – Tuesday August 17 2010 – BridgeHead Software, the company providing Healthcare Storage Virtualization (HSV) solutions, announced that it has appointed 
Tony Tomkys to be the head of the company’s sales operation in EMEA. In his new position, Tomkys is targeting more increase in the UK customers of BridgeHead especially in the NHS and private healthcare sector.
Tony Tomkys to be the head of the company’s sales operation in EMEA. In his new position, Tomkys is targeting more increase in the UK customers of BridgeHead especially in the NHS and private healthcare sector.
Four New Patents Awarded To DatCard For DICOM Images Protable Storage
DatCard Systems, Inc., a leading global supplier of DICOM digital distribution systems, announced today that the United States Patent and Trademark Office has awarded it four new patents, U.S. Patents 7,729,597, 7,734,157, 7,783,163, 7,783,174. The four new patents are each directed to aspects of computing systems that record DICOM medical images and other related data onto portable digital storage devices. In DatCard’s own commercial PacsCube
® product, the storage device also includes a program that allows any user to view the images without the need for specialized pre-installed software. The key technology covered by the patents facilitates sharing of critical medical information with healthcare providers and patients.
® product, the storage device also includes a program that allows any user to view the images without the need for specialized pre-installed software. The key technology covered by the patents facilitates sharing of critical medical information with healthcare providers and patients.
Siemens Healthcare Installs ACUSON X300 At Royal Albert Edward Infirmary
Royal Albert Edward Infirmary, part of Wrightington, Wigan and Leigh NHS Foundation Trust, will perform
portable echocardiograms, abdominal, and chest ultrasound examinations, in its Intensive Care Unit (ICU), after the installation of an ACUSON X300 Premium Edition from Siemens Healthcare. ACUSON X300 PE will be placed in the hospital's Intensive Care Unit. In addition to to the mentioned ultrasound procedures, ACUSON X300 PE will be also used for line placement in vascular procedures.
portable echocardiograms, abdominal, and chest ultrasound examinations, in its Intensive Care Unit (ICU), after the installation of an ACUSON X300 Premium Edition from Siemens Healthcare. ACUSON X300 PE will be placed in the hospital's Intensive Care Unit. In addition to to the mentioned ultrasound procedures, ACUSON X300 PE will be also used for line placement in vascular procedures.
New MRI Advances To Assess Prostate Cancer Severity
Researchers at Rutgers University are working to develop new diagnostic modalities that can help identify 
precisely the severity of prostate cancer through analyzing Magnetic Resonance Images (MRI) and spectra of the patient prostate gland. This may help physicians while select ing the proper treatment according to the condition; some patients may need aggressive treatment while others need only watchful waiting which may be much better. Moreover, physicians may decide to delay or even cancel invasive procedures such as taking biopsies in patients with low-grade tumors.
precisely the severity of prostate cancer through analyzing Magnetic Resonance Images (MRI) and spectra of the patient prostate gland. This may help physicians while select ing the proper treatment according to the condition; some patients may need aggressive treatment while others need only watchful waiting which may be much better. Moreover, physicians may decide to delay or even cancel invasive procedures such as taking biopsies in patients with low-grade tumors.
Subscribe to:
Posts (Atom)